278 related articles for article (PubMed ID: 8211212)
21. Peripheral blood stem cell transplantation as an alternative to bone marrow transplantation: an overview.
Janakiraman N
Henry Ford Hosp Med J; 1991; 39(2):103-7. PubMed ID: 1679756
[TBL] [Abstract][Full Text] [Related]
22. Factors for PBPC collection efficiency and collection predictors.
Ikeda K; Kozuka T; Harada M
Transfus Apher Sci; 2004 Dec; 31(3):245-59. PubMed ID: 15556472
[TBL] [Abstract][Full Text] [Related]
23. Blood and marrow transplantation activity in Europe 1997. European Group for Blood and Marrow Transplantation (EBMT).
Gratwohl A; Passweg J; Baldomero H; Hermans J
Bone Marrow Transplant; 1999 Aug; 24(3):231-45. PubMed ID: 10456992
[TBL] [Abstract][Full Text] [Related]
24. Allogeneic transplantation using peripheral blood stem cells.
Russell NH; Byrne JL
Best Pract Res Clin Haematol; 2001 Dec; 14(4):685-700. PubMed ID: 11924916
[TBL] [Abstract][Full Text] [Related]
25. Peripheral blood progenitor cell transplantation: a replacement for marrow auto- or allografts.
Körbling M; Champlin R
Stem Cells; 1996 Mar; 14(2):185-95. PubMed ID: 8991538
[TBL] [Abstract][Full Text] [Related]
26. Similar outcome after unrelated allogeneic peripheral blood stem cell transplantation compared with bone marrow in children and adolescents.
Remberger M; Ringdén O
Transplantation; 2007 Aug; 84(4):551-4. PubMed ID: 17713443
[TBL] [Abstract][Full Text] [Related]
27. Phase I-II study of high-dose busulfan and cyclophosphamide followed by autologous peripheral blood stem cell transplantation for hematological malignancies: toxicities and hematopoietic recovery.
Ballester OF; Agaliotis DP; Hiemenz JW; Janssen WE; Fields KK; Zorksy PE; Goldstein SC; Perkins JB; Elfenbein GJ
Bone Marrow Transplant; 1996 Jul; 18(1):9-14. PubMed ID: 8831989
[TBL] [Abstract][Full Text] [Related]
28. Randomized comparison of G-CSF + GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells: effects on hematopoietic recovery after high-dose chemotherapy.
Spitzer G; Adkins D; Mathews M; Velasquez W; Bowers C; Dunphy F; Kronmueller N; Niemeyer R; McIntyre W; Petruska P
Bone Marrow Transplant; 1997 Dec; 20(11):921-30. PubMed ID: 9422470
[TBL] [Abstract][Full Text] [Related]
29. Mobilization and transplantation of peripheral blood stem cells.
Shadduck RK; Zeigler ZR; Andrews DF; Gilmore GL; Lister J
Stem Cells; 1998; 16 Suppl 1():145-58. PubMed ID: 11012157
[TBL] [Abstract][Full Text] [Related]
30. Autologous and allogeneic transplantation with peripheral blood CD34+ cells: a pediatric experience.
Watanabe T; Kawano Y; Watanabe A; Takaue Y
Haematologica; 1999 Feb; 84(2):167-76. PubMed ID: 10091416
[TBL] [Abstract][Full Text] [Related]
31. The Nebraska experience.
Kessinger A
Stem Cells; 1995 Dec; 13 Suppl 3():23-7. PubMed ID: 8747985
[TBL] [Abstract][Full Text] [Related]
32. Haemopoietic stem cell transplantation in Australia and New Zealand, 1992-2001: progress report from the Australasian Bone Marrow Transplant Recipient Registry.
Nivison-Smith I; Bradstock KF; Dodds AJ; Hawkins PA; Szer J
Intern Med J; 2005 Jan; 35(1):18-27. PubMed ID: 15667464
[TBL] [Abstract][Full Text] [Related]
33. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
Anderson D; DeFor T; Burns L; McGlave P; Miller J; Wagner J; Weisdorf D
Biol Blood Marrow Transplant; 2003 Jan; 9(1):52-9. PubMed ID: 12533742
[TBL] [Abstract][Full Text] [Related]
34. Peripheral blood stem cell collection and transplantation in paediatric malignancies: a monocentric experience.
Petris MG; De Silvestro G; Cesaro S; Messina C; Marson P; Destro R; Gazzola MV; Masiero L; Carli M; Varotto S; Calore E; Scarzello G; Zanesco L
Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S13-5. PubMed ID: 9989882
[TBL] [Abstract][Full Text] [Related]
35. Primed marrow for autologous and allogeneic transplantation: a review comparing primed marrow to mobilized blood and steady-state marrow.
Elfenbein GJ; Sackstein R
Exp Hematol; 2004 Apr; 32(4):327-39. PubMed ID: 15050742
[TBL] [Abstract][Full Text] [Related]
36. Natural killer cell numbers and activity in mobilized peripheral blood stem cell grafts: conditions for in vitro expansion.
Silva MR; Parreira A; Ascensão JL
Exp Hematol; 1995 Dec; 23(14):1676-81. PubMed ID: 8542964
[TBL] [Abstract][Full Text] [Related]
37. Autologous transplantation with peripheral blood stem cells: a review of clinical results.
Kessinger A
J Clin Apher; 1990; 5(2):97-9. PubMed ID: 1967604
[TBL] [Abstract][Full Text] [Related]
38. Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors.
Finke J; Brugger W; Bertz H; Behringer D; Kunzmann R; Weber-Nordt RM; Kanz L; Mertelsmann R
Bone Marrow Transplant; 1996 Dec; 18(6):1081-6. PubMed ID: 8971376
[TBL] [Abstract][Full Text] [Related]
39. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
[TBL] [Abstract][Full Text] [Related]
40. Allogeneic peripheral blood stem cell transplantation.
Spitzer TR
J Infus Chemother; 1996; 6(1):33-8. PubMed ID: 8748005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]